Monitor Mondays

CMS and Prescription Drug Prices, Part I: 2019 Drug Spending Dashboards

March 25, 2019 Chuck Buck | Ronald Hirsch, MD | Nancy Beckley | David Glaser, Esq. | Mary Inman, Esq. | Edward C. Roche, JD, PhD | Timothy Powell, CPA
Monitor Mondays
CMS and Prescription Drug Prices, Part I: 2019 Drug Spending Dashboards
Show Notes

In the first portion of a two-part series on prescription drug prices, during this edition of Monitor Mondays we report on the Centers for Medicare & Medicaid Services (CMS) Drug Spending Dashboards with data for 2017.

First released in May of last year, the new dashboards include information on manufacturers that are responsible for price increases, plus pricing and spending data for thousands of more drugs across Medicare Parts B and D and Medicaid. Reporting Part I of the series will be Timothy Powell, a regulatory expert and a RACmonitor national correspondent. 

During Part II, scheduled for April 1, Maureen Testoni, president and CEO for 340B Health, will report on the state of the union of the drug discount program.

Other segments to appear on the broadcast include:

  • The Roche Report: Edward C. Roche, RACmonitor investigative reporter and New York attorney, reports on the use of artificial intelligence (AI) to detect fraud in social health insurance programs.

  • CHS Whistleblower Lawsuit: Two former Community Health Systems (CHS) employees have alleged that CHS submitted hundreds of millions of dollars in false claims to the U.S. Department of Health and Human Services (HHS) for federal incentive payments under the CMS interoperability program for electronic health records. The whistleblowers allege that CHS received more than $450 million in incentive payments between 2012 and 2015. Famed whistleblower attorney Mary Inman, partner in the London office of Constantine Cannon, has the latest news on this major story.

  • Hot Topics: Monitor Mondays senior correspondent Nancy Beckley, president and CEO of Nancy Beckley and Associates, reports on all the latest hot topics and will conduct the Monitor Mondays Listener Survey. 

  • Risky Business: Healthcare attorney David Glaser returns to Monitor Mondays with his popular segment, in which he reports on problematic issues facing providers.

  • Monday Rounds: Ronald Hirsch, MD, vice president of R1 RCM, makes his Monday Rounds with another installment of his popular segment.